Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/1996
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013507A1 Synthetic polyunsaturated fatty acid analogues
05/09/1996WO1996013485A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
05/09/1996WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996DE19539860A1 Oral cyclosporin formulations
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203659A1 Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710279A1 Yolk sac stem cells and their uses
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710233A1 Heteroaryl cycloalkenyl hydroxyureas
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710135A1 Extracorporeal Affinity Adsorption Devices
05/08/1996EP0710121A1 Method for treating multiple sclerosis
05/08/1996EP0710110A1 Rapamycin conjugates and antibodies
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1121924A Fruit polyphenol process for production thereof; and antioxidant, hypotensive agent, antimutagenic agent, antiallergic agent and anticariogenic agent each comprising said polyphenol
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514687 Benzopyrido piperidylidene compounds, compositions, methods of manufacture and method of use
05/07/1996US5514686 Use of macrolide compounds for eye diseases
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514654 N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/07/1996CA2099565C N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
05/07/1996CA1338318C Composition for vaccines
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012801A1 Oral immunization with transgenic plants
05/02/1996WO1996012799A1 Neutralization of foof allergens by thioredoxin
05/02/1996WO1996012790A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996WO1996012503A1 Remedy for diseases caused by il-6 production
05/02/1996WO1996012492A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012491A1 Method of inhibiting conditions associated with bradykinin
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2203914A1 Method of inhibiting conditions associated with bradykinin
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/01/1996EP0709459A2 Modified biological material
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0708776A1 Antiallergic imidazoazepines
05/01/1996EP0708771A1 Benzyloxyquinuclidines as substance p antagonists
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708763A1 Process for making hiv protease inhibitors
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708654A1 THF-$g(g)2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0708644A1 TREATMENT OF $i(CRYPTOCOCCUS NEOFORMANS) INFECTION
05/01/1996CN1121715A 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
05/01/1996CN1121430A Inmunization adjusting, anti-inflamation agent
05/01/1996CN1031713C Process for preparing 9-purinyl phosphonic acid derivatives
04/1996
04/30/1996US5512683 Osteoporosis, immunosuppressant
04/30/1996US5512594 Administering to treat a medical condition mediated by one or more leukotrienes
04/30/1996US5512573 Skin irritation; prevention transplant rejection
04/30/1996US5512568 For treating a mammal having a disease state that is alleviated by treatment with an inosine 5'-monophosphate dehydrogenase inhibitor
04/30/1996US5512442 Using specific antibody binding
04/30/1996US5512283 Methods for the selective suppression of an immune response to dust mite der Pi
04/30/1996CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/29/1996CA2154543A1 Human 26s proteasome subunit components
04/25/1996WO1996012031A1 Process for preparing cyclosporin a
04/25/1996WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011943A1 New peptides with immunomodulatory effects
04/25/1996WO1996011925A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996WO1996011920A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996WO1996011916A1 Azole derivative
04/25/1996WO1996011911A1 5-lipoxygenase inhibitors
04/25/1996WO1996011711A1 Saponin preparations and use thereof in iscoms
04/25/1996WO1996011690A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2202623A1 Azole derivative
04/25/1996CA2202056A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996CA2201742A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996CA2201479A1 New peptides with immunomodulatory effects
04/25/1996CA2200628A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/24/1996EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists
04/24/1996EP0708099A1 Tricyclic amide compounds, process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
04/24/1996EP0707577A1 Heme binding compounds and use thereof
04/24/1996EP0689545A4 Macrocyclic amide and urea immunomodulators
04/24/1996EP0380542B1 Method for treating malignancy and autoimmune disorders in humans
04/24/1996CN1121076A 1,4-diazepine derivative and its pharmaceutical use
04/24/1996CN1031641C Process for preparing 8-substituted xanthine
1 ... 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 ... 1172